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Data Crom the literature indicate that nonsteroidal 
anti-inflammatory drugs (NSAIDs), such as indo-
methacin, naproxen, piroxicam, or ibuprofen, induce 
hair loss ill .,i.,o. These NSAIDs are well-known inhib-
itors of both the cytoprotectivc isoform of prosta-
glandin endoperoxide synthase-l (PGHS-l) and of the 
inducible form (pGHS-2). By immunohistochemical 
staining, we found that PGHS-l is the main isoform 
present in the dermal papilla from normal human 
hair Collicle (either anagen or catagcn), whereas 
PGHS-2 was only faintly and exclusivcly expressed in 
anagen dermal papilla. Thus, PGHS-l might be the 
pritnary target of the hair growth-inhibitory effects 
of NSAIDs. We thus speculated that activation of 
PGHS-l might be a mechanism by which minoxidil 
M illOxidil is a pyrimidin e derivative (2.-I-di'lltlillo-6-pipcridin opYI'il1lidill c-3-oxydc) illitially de-veloped as a potent anlih ypertensive agent (Uargie ('I rd. 1977. Devine ('I al. 1(77). In ndd itioll to being a direCl-acting vasod ilator. it 
was unexpectcdly foulld to stimlllate hair growth ill "i"" (Weiss 1'1 
al. 1984). This m ajo r side effect in hYI ertensive treatment led to its 
clinica l usc for the trl'oltmellt of cOl1lmon baldness (androgenetic 
alopecia) and alopl'cia arcata. Milloxidil was later I'e portcd to 
stimu late a timc-depcndenl ill crease ill "If 'I-thY1l1idinc and '\SrS /-
cysteine incorporation in mouse vibris~a tClllides in orga n culture ;/1 
vitro (Buhl 1'1 al. 1989) . Although it has becn recently ~ uggested that 
both anti-hypertensive alld hail'- regrow l h e ilecls were due to thc 
action of' its ~ ulfil ted l1Ietabo li te (l1linoxidiIS) 0 11 K I chann e ls 
(Meisheri el al. 199 1; Buh l c( ai, 1992<1). 11 0 unifYing COll ccpt 
explain by w hich hiochc mical l11cchallislIl(S) Illinox idil can cxhibit 
its pleiotropic enects. For exa mpl e. milloxidil Iws a lso been re-
ported to inhibil lys)'1 hydroxy lasc ill "ilm ill humall dermal 
fibroblasts (Murad ('I al. 1(92) ,,< well as in f-ibroblasts Ii-olll tlte 
externa l cOlln ective tis~ue sheath ofhlllmn hair fo lli clcs (Maht' ('I "I. 
1996). T h e exact way by which it stim ul ates hair growth ill "i"" is 
still a rna tter of debate. 
Other drugs arc known to in te l·fere with the Iw ir cycle. OllI e 
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(2,4-diamillo-6-pipcridinopyrimidillc-3-oxyde) stim-
ulates hair growth ill "i"o. We demonstrate here that 
minoxidil is a potent activator of purified PGHS-l 
(AC50 = 80 p.M). as assayed by oxygen consumption 
and PGE2 production. This activation was also evi-
denced by increased PGE2 production by BALB/c 3T3 
fibroblasts and by human dermal papilla fibroblasts in 
culture. Our findings suggest that minoxidil and its 
derivatives Inay have a cytoprotective activity ill "i"o 
and that Inore potent second-generation hair growth-
prol1.10ting drugs might be designed, based on this 
mechanism. Key UlOJ,ds: lfIilloxidillprostaglalldill s}lIItIJasel 
"ail' .'Of"(,,,,t'" CJ'toprotectioll. ] I/IIIest D erlllatol 108:205-209, 
1997 
(e.g .. a llri n eopl a~ lic age n ts, such ~s doxorubicin) induce all abrupt 
n:ssation of mitotit: activity. Others such as J3-blockers, interferons. 
or reti ll oid~ (Pi llans and Wood, 19(5) prccipitate a premature 
resting phasc (te logell etRu \·ium) . ' il11ilarl),. ami-inRatlll1wror) 
agc'n ts such as indomcthacin. naproxell. piroxicall1, or ibuprofi.'n 
provoke hair loss (Tosti el al. 1994; Pillans and \Vood. 1995; tor 
revicws). Because thesc compound, inhibit thl' prostaglandin en-
doperoxide synthases (PGHS-I. E. '" 1.1-1 .99. 1, and PGHS-2. 
E.C . \ . 14 .<)9 .2). which catalyzc thc first IWO step' oCtile arachidnnic 
ac id cascadc (Sm ith and M:lrllelt, 1(91). it is possible tbat al \ea~t 
o nc of these iso(onns is active in hair growth. Minoxidil has also 
been reported to affect the metabolism of arachidonic acid h) 
inhibiling prostacyclill synth asc in bovinc aorta cndothelial cells 
(Kvcdar l'I al. J 988) or increasing prostaglandin E2 (PGE~) produc-
tioll by dermal papilla fib roblasts ill culturc ;/1 "ilm (Lachgar rt al. 
1996) . Wc thus investig<l!ed w hether PGIIS- I and PGHS-2 i,o-
torlllS werc expressed in human hair fl)lIiclc~ <lnd whether ll1ino,idil 
was a modu lalor of thcsc two key cnzyml'~ of the arachidonic acid 
cascade th ,lI is involved in the gcneralion of prostaglandillS. 
MATERIAL ANn M T II O))S 
C hemicals PCE, was obtained li'om CaYlIlan Chemical Co. (Ann Arbur. 
MI) . Arachidonic acid aud indol11cthacin '" l'a' ohtained fnlTIl Sig-111a ..1H,,'II1-
ic;oI COlllpan), (Sai llt -Qllentin Fa ll avier. France) . Potas,ium "r"chid"n"tc '"(, r 
assay' wtl' prepared according 10 the C.1)'Hlan Cl lcmieal, Compan)' proCl'-
dure :IS rollows: 100 ILl or cold (0 S"C) n. I M i'll/assiulII hydrn"ide "erc' 
added to 95 ILl of ('chanol conl,lining 4.5 IIIg or ,Ira hid"nic acid Jnd 
lhoroughl), lIIixed . Then. 2 Inl ILl uf water (tree or redox aen\,,' tramilion 
nletal ion') were "drkd and nlixed to oht,lin .1 eIL-ar 'olution of 6.7 111M 
potas\iutt ' ar~H"hidonatc that could be added directly to rhe n'\~ay Inixtllrl.' 
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(stored at 4"C protected from light) . L-Glutaminc, pcnicillin/streptomycin. 
and 199 tl'Il!dium were supplicd by Gruco (Cergy Pontoise. France). 
Biologic Materials Ovinc prostaglandin endoperoxide s}~1thase- 1 
(PGHS- I) (E.C. 1. 14.99.1) isolated from sheep seminal vesiclcs, was 
purchascd from Cayman Chcmical Co. Human scalp biopsies wcre obtained 
from female face-lifting surgcry with patients' consent. They were cut into 
small pieces under a microscope. each piece contain ing about six intact 
follicle<. Tissue samples were thcn coated in Tissuc-Tck O.C.T. from Miles 
Inc. (Elkhart. IN). quick frozen over dry icc (- 80"C), and stored at - 80°C . 
Immunohistochemistry Longitudinal sections (5 J.lm) of hair follicles 
were obtaincd with a cryostat HM 500 M (Microm. Francheville. France) 
set at - 40"C. Sections were air dried and stored at + 4°C ovcrnight before 
processing. Sections were thcn fixed in acetone at - 20 ' C for 10 min 
tollowed by scveral washes in phosphate-buffered salinc. Endogenous 
peroxidase acriviry was quen ched by imml!rsing the sJjdcs in 0.1 'X, hydrogen 
peroxidc for 10 min. To block nonspecific binding sites and minimize 
background. the scctions were thcn covered with I % nonfat milk-phos-
phate-buffered saline for 15 min. Thc following primary antibody dilutions 
in phosphate buffered saJjne containing 10% of goat nonnal seru m were 
"pplicd ro the sections for 18 h at + .j0C: the mouse IgG' b ITom the cyo- I 
hybridoma cell line anti-PGHS-l monoclonal antibody (MoAb) PG21 
(Oxford Biomcdical Rescarch. Oxford. MI), wluch was developed against 
ovine PGHS-I and reacts with human PGHS-I (DeWitt et aI, 1982). was 
diluted to 1:8. The mouse IgG, (clone 33) anti-PGHS-2 MoAb C22420 
(Tran<duction Laboratories. Lexington. KY) was diluted to 1:25. Biotinyl-
ated goat anti-mouse immunoglobulins (Dako, Trappes, France) were 
applied for 30 min at rOom temperature. Strepavidin biotin peroxidase 
complex was prepared as indicated by the manufacturer; sections were 
covered with the <trcpavidin biotin peroxidase complex solution for 30 min 
at room temperature. Substrate so lution (AEC. Sigma. St. Quentin FaJla-
vier, France) was prepal'cd and :.pplied for 6 min as indicated, and the color 
reaction was then stopped by washing with double distilled water. The 
slide< were finally mounted wirh cover glasses using glycerol gelatin (Sigma) 
before ob<ervatioll under a light microscope. Because we found no staining 
of any compartment of the catagen hair follicle (sec Results) with the mouse 
IgG I (clone 33) :tnti-PGHS-2 MoAb C22421J as the primary antibody. tius 
antibody served as a negative control showing thar rhe biotinylatcd goat 
,mti-Illouse imlllunoglobulins were not responsib le for the staining we 
observed using allti-PGHS-I MoAb. Additional negative controls were 
performed by replacing the primary 'II1tibody with phosphate-buffered 
saline; rher gave the expected negative results (data not shown). 
Cyclooxygenase Activity Assay Cyclooxygenasc activity was mea-
sured at 37°C by monitoring oxygen cOllSumption in a SOO-/-LI incubation 
ce Il connected to a Clark electrode (DW I electrode unit and Cll I .0 
oxygen control box. Hansatech Instruments. Norfolk. UK). For measure-
ment of oxygen consumption in the pre,cllce of minoxidil. the oxygraph 
cell chamber wa, filled with 424 /-LI of 0 .1 M Tris-HCl buffer (pH B.OO) 
containing 5 mM EDTA and various concentrations of minoxidil (0 J.lM-
425 /-LM). Then 1 nl) nM of PGHS-1 (from a stock solution. 0.235 mg of 
R2.000 units mg/ ml) withour phenol and exogenous hemin was added and 
after I min of incubation, the reaction was <tarted by the addition of 10 J.ll 
of 6.7 mM potassium arachidonate (fiua l concentration, ISO J.lM). The 
oxygen consumption was calculated with the assum ption that at 37°C, 260 
J.lM of O 2 was dissolved as described (Na<tainczyk el til. 1984). 
High Pressure-Liquid ChromatographylEnzymatic Immunoassay 
(EIA) Analysis Three individual and distinct experimenta l reactions 
between PGHS-I (170 nM).minoxidil (500 J.lM), and arachidon ic acid (ISO 
/-LM) in :. total volume of SOO J..l1 were monitored for oxygen con<ull1ption 
at 37°C . Samples (50 J.lI) were then taken after completion of the reaction 
(as evidenced by rhe ab<ence of ox)"gen uptake). kept for 30 min at room 
temperature, and then stored at - 80°C . It was shown that PGH 2, which is 
un<tahle under the,c conditiOn<. formed stahle corn pounds (respectively 
V .E , and 15 hydropetoxy-PGE2) by nonenzymatic decomposition. The 
yieli of tltis spontaneous dccompo<irion was about 90%, with I rrY<, of PGH, 
being converted to PGD, (Eling .'1 nl, 1991). To measure PGE, fo rmation 
and avoid :lny interference \viLh arachidonic acid in the EIA .;;ystcrn , we 
performed an "X traction prior to HPLC puritication based on a method 
de"eloped by Kelly I't al (1989). ErieAy, each sample wO' acidified with 20 
/-LI of glacia l aCl'tic acid and centrifuged at 2500 X g for 5 min. Supernatant 
wa< removed and applied to a I OO-mg C ,• l3akerbond column (Amersham. 
les Uli<. Francl'). The column wa< then washed with I vol of distilled water 
and I vol ofhcxanc . Prostaglandins were e luted with two-column vo lumes 
of ethyl acetate. Each fraction W:1S evaporated LInder nirrogen, and the dry 
residues were di<mlved in SOO I.d of methanol. 
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HPLC The H.PLC sys tem (6005 controller, 616 pump, 996 pbotodiode 
array detector, and Millenium software) was from Waters Associate 
(M.ilford. MA). Each fraction containing PGEl was co llected after HPL~ 
<eparation using a Waters Nova-Pak C,~ 4-1"111 (3.9 X 150 mm) column 
(Waters Associates). Thl! mobile phase was IIl cthanol /wateritriftuoroacetic 
acid (70:30:0.1) for the first 4 min. foll.owecl by a linear gradient of 
methanol/triAuoroacetic acid (100:0.1). which was maintained for 10 min at 
a flow rate of1 ml/min. Under these conditions, PGE, and aracludOllic acid 
standards were detected at an elution time of 2.9 min and 11.4 m.in 
respectively. Because PGE2 genctllted ill lI; tm was below the HPLC detec~ 
tion level. the undercctable PGE2 sample fraclions were thus collected at 2.9 
min and evaporated using a vacuum device frol11 Heto (A llerod. Denmark) . 
The dry residues wcre disso lvcd in 100 J..lI of EIA buffer, and their PGE 
content \\las as~aycd using a 1110rc sensitive EIA SYStCI11 Biotrak fro~ 
Amcrsham International (Buckinghamsh.ire. England) . 
Cell Culture Fresh samples ofhlllTI:1I1 sca lp ski n wcre rapidl y dissected a 
prcviou.l ly dcscribed (Philpott 1'1 nl, 1990) under a stereo c1issecting micro_ 
scope using a sca lpel blade and watchmaker's forceps. Individual isolated 
follicle units were placed in .100- 111111 culture di shes (Corning Glass Works 
Coming, NY). Dennal papillae were microdissected as dcscribed (Messen~ 
ger, 1984) and cultured in Medium 199 containing 2 mM L-glutami.ne, 1% 
of an antibiotic/antimycotic Solu lion. and 10lyo fetal bovine se rum (GIBCO) 
at 37°C, 5'X, CO,. At the time of the first passage the dermal papilla 
fibroblasts were seeded ill 24-wcIl plates from Costar (Cambridge, MA) at 
a plating density of 5 X 10' cell s/em 2 • T hc ce ll s were cullured for 16 h in 
10% fetal calf serum-supplemented Medium 199 . Next, 100 fLM minoxidil 
was added to ti,e culturc mcdium. and the ce ll s were furti1Cr incubated 16 h 
at 37°C. Milloxid.il was dissolved in (20:RO) ethanol/water, the final 
concentration of ethanol being < 1 'X,. PG E, amounts were directly estimated 
using a Biotrak PGE, EIA system (Amersham Intcmational. Buck.ingham_ 
shi re. England). BALB/ c 3T3 fibrobla<ts (clone A31) were obtained from 
American Type Culture Collection (ATCC, Rockvi ll e. MD) . Cells were 
seeded into 24-well plates at a plating density of 10J cells/ cm ' . The cells 
were cultured for 16 h in 10'X, feml ca lf <erum -< upl'l emented Medium 199. 
Minoxidil (100 J.lM) was lidded to the culture IIledium and PGE, productioll 
measured under the same condi lions <IS we used for dermal papilla 
fibroblasts. 
RESULT ' 
Localization of PGHS-1 and PGHS-2 Isoforms in HUnlan 
Hair Follicles Usin g specitlc M oA bs, we first determined which 
PGH-S isoforrns were expressed in the human hair follicle and in 
which hair follicle compartm e nt. As shown ill Fig 1, we observed 
that PGHS-l was produced in the lower p<trt. of the hair follicle . 
PGHS-l protei.n was stro ngly (and pt'eferentially) expressed in the 
dermal papilla cell s during anage n (Fig 1a) and late ca tagen pha 'c 
(Fig 1/J), suggestin g that PGHS-I is present in these ce lls through_ 
out the hair cycle. In contras t, labeling with MoAb against PGHS-2 
showed very weak staining of anagen dermal papilla cells (Fig le) 
and no staining of late catagen dermal papilla ce ll s (Fig Id) . In 
addition , strong expression of PGH~-l was detected in the perifol-
licular epidermis (Fig 1c) in the absence of expression of PGHS-2 
(Fig 1.1) . These result.s indiGlte that PGHS-l is the mai]l isoforrn 
expressed in the hair follicle and in the perifollicular epidermis and 
additionally they show that its location is restricted to tbe d ermal 
papilla during the human hair cycle. 
Concentration-Dependent Enzymatic Activation of 
PGHS-l by Minoxidil 111 Vitro Uccause PGHS- I is the major 
isoform in human h air follicle, and lakin g into account that based 
on 91 % protein sequen ce homo logy of human and sheep PGHS-l 
(Smith and Marnett, 1991) a nd that sheep P<..;HS- 'I is widely u sed 
as model for human PGHS- I in mechanistic studi 'S, we investi-
gated the sen sitivity of sheep PGHS-I to minoxidil. As shown ill 
Fig 2,PGHS-l is strongly activated by minoxidil. The activation of 
PGHS-l by minox idil is evidenced both by an increase in the slope, 
indicating an ,JCceleration of the cata lytic process, as well as by an 
inc rease of the to tal O 2 con sumption compared with the control. 
(arachidonic acid a lon e). Moreo ver, as shown in Table I , rhi 
activation is con centration-dependent, and the ACSO for PGHS-l 
dctivation was 80 J.LM. As expccred. the PGHS inhibitor indometh-
aci.n completely inhibited the PGHS-I activ ity (Table ll) . The 
calculated total amounts of O 2 consumed under the different 
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Figure 1. PGHS-l is the major PGHS expressed in dermal papilla 
frOttl anagcn and catagen hun"m hair follicles. Lottgiwdi01i11 <cnioll 
of hrur follicles were incubated wil h eilher :lIlti-PG II S-1 (",II) or anti-
PGHS-2 (r,d) MoAhs for I ij h "I 'J"C prior 10 pl'roxid",e stililling' as 
indicated in 1I[(/le";,II-, "",1 lIlellt"ds. Alla~cll hair fo llicle (",r). Cat"g'c ll hair 
follicle (11,d). Note the weak expressil)ll or I'GH '-2 ill dermal papilla [r0111 
8nageD hair rollicle alld the );Kk of expression of PC; I [S-2 ill de'rlll,Ii papilla 
from catagen hair /(,lIicie (d). COlll ro l l'xpl'Till l ~lll 'howill~ Ihe cxpn'"inn of 
PGHS-l (I) bllt lIot of" PGHS-2 (I) ill the t'piden lli ,. Sra,," hal', 50 ",Ill. ~ , 
dern13] papilla 
stimulation condition s (sec Table I alld Table II) indicate' that the 
oxygen uptakc in respollsc to minoxidil can be iJlcrcased Lip to 
2-foJd compared wirh the control. Furthermore, ' I sil11i lar increase 
(Xl.53) in the amount of PGE2 was gellerated i" piln> hy the 
purified PGHS-.1 in response to minoxidil (see Table U) . 
Induction ofPGE2 Minoxidil Production in the Supernatant 
of Dermal Papilla Cells and BALBlc 3T3 Fibroblasts in 
Culture [II Vitro To a~cerLain that the PGHS-I activation by 
mjnoxidil demonstrated at the enzymatic level was hiologically 
signi ficant, the production of PGE2 by li ving dermal papilla cells 
and BALBlc 3T3 ~ibroblasts was also ll1easured in response to 
minoxidi l. Fig 3 shows that 100 iJ-M minoxidil induced prod uction 
ofPGE2 in the supcm atant ofhllln<ln dermal papilla 6bl"Obla~ts (Fig 
Ja) as well as in that of BALBlc JT3 ~ibroblasts in eulture ill "ifr" 
(Fig 3b) . PGE2 production (pg/ml) was significantly increased (p <-
0.05, n = 10, I.Inihlteral t test), up to 17'% hy dermal papilla 
fibroblasts treated with mino idil compared withollt control Ull-
treated cell s (from 75 :t. 13 to 88:': 20, mean + SU). III BALBlc 
3T3 fibrob lasts PGE2 production was also ~ignili("alltly increased (p < 0.05, n = 4, t test), up to 28'X, after minoxidil treatlllcllt 
(from 107 :': 2 to 137 :': II), mean .!:: SI). At this concentrarion 
(100 fLM) , lninoxidi l had no effect Oil thc proliferation rMe or tire 
treated cells (data not shown) . In control experiments, as expected, 
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Figure 2. Enzymatic activation of purified PGHS-t ;" ";('" by 
rninoxidiI. O"l'!;CIl con~lIlllpti()n by plIritil'd O\'ine PGHS- I (E .. 
1.14.99. 1) "'as lllonitorl'd at .17°(: wilh "c.llihratecl brk ell'elrodl' a, 
illdicnlc { in ~\J(t( (',i(f{s dllCi "lft/1I1,ls (r~slllts (r\Jtl l ('I Ii C representative...' experi-
ment) . At I = n, I () /-,1 of suh.,trate' for PGHS-I (arachidonic acid ,It d hnal 
CO llcclltratl()1l of 150 J..l..M) were added and chang'c(j ill oxyg-en C01lsu1l1ptioll 
\\ ere illlllll'diatly recordl'd t<)I" 50 , . (-0 -) Comrol withol11 lI1ino"idil : (-e -) 
SO() I-lM Illino;\idil. 
SO iJ-M indomethacin strongly inhibited ( - 95%) PGE~ producrion 
by HALB/ c 3TJ (I' 0.0 1, t test, n = 6) as reported b ' Dancsch 1'1 
ai, 1994. Additionally, 20 /-lM indomethacin also significantly, hilt 
to a lesser cxtent (i.e.. 16%) (p < (I.n I, ItcH, n = 10), inhibited 
PGE~ production hy dermal papilla ce lls ill eu/rurl' ill !'ilro (data not 
shown). 
DISCUS ION 
PGHS-I exhibits two distinct and complementary enz ymatic acn,·-
itics : a c),c looxygenase activity tbat transforms arachidonic acid inlO 
PGG! alld a peroxida,e acti"ity that reducc, PGG 2 to PGH2 (Smith 
alld MUn/ctt) . PGI1 2 is lhl'n cOllve'rted, dq1endillg on cells or tissue 
I)'pe-spcci~ic iSOl11cnlses, to a combination of prostanoids (PGE2 , 
PGD2 • PGF2a, PGI 2 , alld TXAJ lhat have il1lportanr and plcio-
tropic biologic ettcct~, usually in an autocrillc or paracrillt' l1lanIlCl' 
(DeWitt, 1991; Smith and Mamctt, 19(1). 
Two PGHS isoenzYl1lcs have been characterizcd. The ~irsl 
i,ofol'm (PG HS-I), initially puri~ied :lI1d cloncd from shecp \'esic-
lIlar glands (Miyamoto ('I ai, 1976; Van del' Oudcraa eI ai, 1977), i< 
" hOlllodirner 0(70 kl)a constitutively l'xpre, sed ill most tissues and 
vl'r), well conser\'cd among species . omplel11entary D A fOf 
sheep, mouse, and hllllHUl PGII ha\'e been clolled (De Win and 
mith, 1988; Merlie 1'1 11/, 198R; Yokoyama I'f a/, 1988; Yokoyama 
and Tamlbe, 1(89) and amino acid ~equenn's of tl1l' PGH -proteins 
deduCL'd . The result.s showed B8% <equcnce identity between the 
shcep alld till' mouse enzyme and 91 % betwecn the sheep and the 
hUl11an en7Yllle. Although PGI-/S-I is e, ,ential for the hOllleostasis 
of m:lIll1nalian ("ells (Vane and Botting, 1(95), lhe sccond isofonTl 
PGI-/S-2, which presents flO'X, homology with PGHS-I , is reportl'd 
to be inducible . 
Pro-inflamlllatofY c}'lokines <Ilch as inlerkukin-l and rumor 
nccrosis factor-a ;IS well as g-rowth fa ctors weh as cpiden11al growth 
factor arc transniptional activators ot" PGH -2 ( ' ic ('/ nl, 19(2) . 
' onsequcl1t1y, PGHS-2 is lh~ target of choin' for llotl<ceroidal 
ann-inflammatory drugs. By t"oncra~t, inhibition of the cytoprotec-
tive l'nZyllle PCHS- 1 i< detrimental to cytoprotc("tion (a< l'vide'need 
by tlrc well-known deleterious elf('Cts of the 1I0nse lectin' nonste-
roida l allti-infbnlln'lIory drugs, aspirin and indonl('chacin, on gas-
tric cells) (Battis!ini /'1 til, I Q94; Valle :md Botting, 1995). Despite 
being- HfOngly cxprc<scd borh at the mRNA and protein levels in a 
controll'xperiment (i.e ., dermal papilla (Dp) cells in cu lture ill pil .... 
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Table I. Concentration-Dependent Activation by MinoxidiJ of Total Oxygen Consumption by Purified PGHS-l" 
V,,,,,. (kata l (molls) X 
-----
Total O 2 uptake (J.LM) 10.1) 
Minoxidil (J.LM) Exp. I Ex p. 2 Contro l" ("!o) Exp. I Ex p.2 Control" ("!o) 
3.02 3. 02 
-----
425 34.8 34.8 210 215 
215 27.0 34.3 185 2.54 2.70 188 
100 25.0 26.5 155 2.28 2.3 4 165 
45 21.7 21.7 131 1.97 1.72 132 
20 21.8 20.8 128 1.87 1.77 130 
0 16. 1 17.2 100 1.30 1.5 1 100 
. 1 Oxygen t."onsumptioll by pu rifi ed ovinc PGH S- l &U1II sheep .. e rn ina! vcs i(." lcs (E.C. 1.14.9(j . 1) W<1S l11ollilOfCd al 37°C w ilh a r., lihratcd C l:irk elect rod e in tli t..' pl"es '" --:--511h ~tratc for PGJ-IS- I (arach ido nic acid ac a fill:ll COll cclltfntiOIl o/" 150 JkM) and in crc;lsing COII CC I11ration (0-425 JJ,M ) o f min ()xidi l a\ indicated i1l I\'III/crials alit! l\ff'fh" r/s . T~~~;-~;r 
uptake was recorded at I min after the heginning of each reaction . ~ 
I, Percellt ('1.\) of ("omrol is calculated fr011l th«.! mean of each g-rnup o/" valu es. ACSU = 80 JLM (rcprcscntn t ivc cXPCri IllCIH) . 
stim ulated with interieukin-lJ3 50 ng/ ml ; data not shown) , 
PGHS-2 isotanl1 could be only faintly de tected in norm al anagen 
DP cells. T his suggests tllat the PGHS-J isoform is the major source 
of prostaglandin production in the DP of both anagen and catagen 
human hair follicl e. Recent data on the PGHS-l knock-out mouse, 
however, support the hypothesis that PGHS-2 could also contribute 
to the basal level of prostagland in production necessa ry for normal 
homeostasis (Langenbach el aI, 1995; Morham 1'1 aI, 1995) . Thus, 
because we observed that minox idil (500 fJ-M) could also signifi-
can tl y (+ 160°/.., P < (LOS, t test, n = 3) activate purified sheep 
pla cental PGHS-2 (E.C. l .14.99.2) ;/1 1I;lro (data not shown), it is not 
totall y excl uded that in no rmal anagetl. not on ly PGHS-l but also 
PG HS-2 might be the targe t of minoxidil action. By contrast, the 
faillt expression ofPGI-lS-2 observed in anagen dermal papillae was 
lost in c~ltagen DP cells. Whether this extinction of PGHS-2 in 
catagen DP cells is the ca use or a consequence of the o'ansition from 
anagen to ca tagen remains to be established . 
During tile metabolism o f arachidonic acid by the PGHS-l , many 
xenobio t ics, such ,IS aromatic amines or pheno l, may act either as 
co-substrates for the peroxidase activity or may reduce the inter-
m ediate iron-oxo species into reduced iron (llI)-PGHS, by two 
one-electron transfer reactions , leadin g to the protection (aga inst 
"suicide" inactivation) and activation of PGI-lS-1 as evidenced by 
enh anced oxygen uptake necessary for the cyclo-oxygena tion of 
arachido nic acid by purified PGHS-l ;'1 Il ilm (Markey el nl, 1987; 
Elin g el aI, 1990; Mahy el aI, 1993 ) . We fOllnd that the hair 
growth-promotin g dru g minoxidil, w hich could be considered as 
~1l1 aroma tic amine, activated PGHS-l activity ;/1 Ililro. T he ex pected 
m etabolite of thi s reaction is prost;lglandin H z (PGH z), wh ich 
spontan eo usly decomposes into PGEz and 15 hydro peroxy- PGEz ;/1 
11;11'0 (Eling el aI, 199 1). Using a two-step procedure (i.e., I-lPLC 
purifi ca tion fo llowed by EJA determination) , we measured the 
increase (+ 53'V,,) in PGEz syn th esis by purified PGHS-l as a result 
of this e nzym atic activation ;/1 lI i/ro. A stoichiometric relation 
Table ll. MinoxidiJ Induces Oxygen Consumption and 
PGE2 Production by Purified PGHS-l III Vitro" 
Minoxidil Indomcthacin 
Control (500 iJ.M) (100 iJ.M) 
Total o"J'gen 
uptake (J.LM) 12 (:!c O.7) 27" (:!c 1.3) 0" 
Control (,X.) 10{J 225 0 
PGE2 (J.L M) .5 (:!c0.3) 2.3" (:!c 0.l5) 0" 
Control ('Yo) 100 153 a 
.1 According to lhe descri pli o n by Eli ng (Eling el nl. 199 1). The reac tion medium 
frvrn rhe C lark electrode cclI chamber after com pletion of the j" (fj,m reaction was 
eva luated for PG E2 CO IH t'nt using .U1 enzyme illlJ1llll1 oass;JY (EIA) a.'i dClicrihed in 
A1atc,.;tlls (llId Alef/uuls after HPLC puri fication. Arachidonic ilcid '150 j.l.M. Mean ~ SD. 
J1 = 3. 
I. An ill ysis of v;lrian cc: p < U.05. Ovinc PG HS-I was isolated frOI11 ~hccp ~emina l 
vesicle>. (EC 1. 14 .9'1. J) . 
bet",I'een O 2 consumption and PGEz fo rmatio n cou ld not b~ 
established because the spontaneo us yie ld of decomposition ' 
PGH2 into P~E2 ;/1 1I;£ro is not c1.ea rJy known (~Iing ('I aI, 1991 ) al'~~ 
probably vanes un~er th e ex peTlmental condlt1 ?ns. The increase ill 
basal O 2 consumpoon and ba sa l PGE~ ProductlOll, however. were 
similar (i .e., X2 .2 and X I.5, resp~ctlv.e l y). We furth er o bse r ved 
that the activation ofPGHS-1 by I11lnOXldil i/l 1;lro is concentratio
n
_ 
depcndent in the mi croll1o lar ran ge (AC50 = 80 fJ-M) . Th.is 
activation was ev idenced both by ac~e l eration of O 2 conSllmption 
durin g the reaction of cyc!o-ox),ge natlon o f arachidoll ic acid as weU 
,IS by an increase in the amount of total O 2 conSUl1led compa red 
with a control exp eriment in thc absence of minoxidil. . 
W e found that thi s activation was not res tricted to the DP cells 
because murine 3T3 fibroblasts also respond to minoxidil with 
significa nt (+ 28%; p < 0 .05) increase in PG Ez production in th: 
supernatant (from 107 pg/ml to 137 pg/ml) . T hese data are 
consistcnt with observations b y oth ers indi cati ng that DP fibroblasts 
grown ;'1 v;/ro respond to min ox idil by producing at I.east PGE 
(Lachgar cf aI, 1996). It is no teworth y that the effects observed i~ 
this study, as well as most o f the bi o logic and chemica l effects of 
minoxidil reported ;/1 lI ilro. sll ch <lS inhibi tion of Iysyl hydrox'y lasc 
(Murad 1'1 aI, 19n). inhib ition of ker<ltinocyte proliferation 
(O'Kee fe and Payne. 1 <}9 1), and inhibition of prostacyclin synthase 
(Kvedar cf aI, '1988), occur at concentration s higher (in the 25-1000 
fJ-M range) th '1I1 those achie ved in serum after eithe r topi ca l or oral 
administration of the drug (0 .02 fJ-M to 0.7 .fJ-M, respec tively) 
(Orfan os, 1990) . Because an aCCUl11l1l HIOn ot minoxidi.l in the 
epithelia l m atrix ce lls of hair folli cles j ust ;Ibovc Auber's critical line 
(i.e. , adjacent to the derl11a l papilla) has also b ' en d escribed atter 
topical application (B.uhl 1'1 aI, 1992b), this apparent discrepancy 
may be related to oss ll e concentra tIo n of the drug i/l lIil'<1 in 
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Figure 3. Induction of PGE2 production in response to minoxidil 
by fibroblasts in culture i" vitro. PCE, production levels in supernatants 
from either control or 16-h J1linoxidi l- trcated ce ll s ( I Of) J.LM ) were evaJu-
~Ited using an EIA as dcscribed in Alnlcr;als amI i\lNIt"ds. Supcmatallt fr01l1 
dermal papilla fibrobl:l sts of bUlIlan hair follide l ill culture ;/1 I/ ;Iro (mean 
values from four we lls) (a) . S llpcm~Ha Ll l from BAL131c JTJ fIbroblasts in 
culture (mean v~llu cs ITOi'll 10 we ll s) (I.). • Indica te, results that diifer 
significantly from COlllrol (I' < 0.05. unil:ltl'ra l t test) . 
VOL. 1 (lR. NO. 
prox1IT1ity to the derma l papilla in which PCHS-I ncti"ation or 
protection might occur. 
In humans. O lsen and Delong ( I <)!)() showed no bencficial dl""ct 
of the PGEz nna log yiprostol on androgt'netic alopecia. The lack of 
activity of yjpro~tol in their study might be duc to eit.her an 
inadequatc frcqu c ncy orapplication (twice daily) or a conccntTation 
inadeq uate to support sus iaincd exposure of I»> ce ll s or adjaccnt 
matrix cells to PCs . By contra~t. more recent studies (Ma lkinwl1 1'1 
aI, 1993) have shown a cytoprole tive effect of PC El ngninst (·ither 
radiatlO I1- or doxorubicin-induced hair loss ;/1 I';"" (on 1110u.'e dorsal 
skin) W"ith a maxima l activity 2 h after applic,lti on (and a total loss 
of protective 'lc tivity of PGEl 4 h after app lication). furthermore. 
topica l app li catio n of the PC IIS inhibitor indomethacin was found 
to delay hair growth ill ";11" in Illice . I Together. these obscrvatiom 
strongly suggest th ;lt the cytoprotectivc ('ffect of llIinoxidil that we 
descri be here shou ld be considen:d in the complcx process by 
which ll1inox idil sti mulates hair n:growrh ;/1 1';1'''. 
~Ve lII;sh 10 " ;,,cc,.d)' Ih""k /,,.. n,.. 1-1",1.' S,h",ji.,.""d D,.. (:I,,,,c/,, /J,,,,ill,,,, ./i.,.,h,.,.,. 
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